X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-08 | ANNX | Carson William H. | Dir | P - Purchase | $6.07 | +3,200 | 3,200 | New | +$19,411 | ||||||
| D | 2024-02-20 | ANNX | Lew Jennifer | EVP, CFO | S - Sale+OE | $5.53 | -2,593 | 82,058 | -3% | -$14,339 | |||||
| D | 2024-02-20 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale+OE | $5.51 | -2,604 | 93,471 | -3% | -$14,348 | |||||
| D | 2024-02-20 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale+OE | $5.48 | -1,951 | 85,641 | -2% | -$10,691 | |||||
2024-02-12 | ANNX | Overdorf Michael | EVP, CHIEF BUSINESS OFFICER | S - Sale | $5.53 | -1,349 | 48,592 | -3% | -$7,460 | ||||||
2024-02-12 | ANNX | Love Douglas | Pres, CEO | S - Sale | $5.54 | -5,782 | 196,121 | -3% | -$32,032 | ||||||
2024-02-12 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $5.54 | -1,809 | 45,651 | -4% | -$10,022 | ||||||
2024-02-12 | ANNX | Yednock Ted | EVP, CHIEF INNOVATION OFFICER | S - Sale | $5.54 | -1,810 | 57,075 | -3% | -$10,027 | ||||||
| AM | 2023-07-11 | ANNX | Yednock Ted | EVP, Chief Innovation Officer | S - Sale | $4.49 | -22,057 | 58,885 | -27% | -$99,021 | |||||
2023-07-11 | ANNX | Overdorf Michael | EVP, Chief Business Officer | S - Sale | $3.84 | -978 | 45,802 | -2% | -$3,752 | ||||||
2023-07-11 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $3.84 | -1,057 | 47,460 | -2% | -$4,055 | ||||||
| D | 2023-12-27 | ANNX | Yednock Ted | EVP, Chief Innovation Officer | S - Sale+OE | $4.52 | -21,000 | 0 | -100% | -$94,966 | |||||
2023-12-26 | ANNX | Satter Muneer A | Dir, 10% | P - Purchase | $2.88 | +350,000 | 7,406,024 | +5% | +$1,008,000 | ||||||
2023-05-25 | ANNX | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $2.13 | +300,000 | 5,701,926 | +6% | +$639,720 | ||||||
2023-02-15 | ANNX | Love Douglas | Pres, CEO | S - Sale | $5.87 | -6,571 | 197,646 | -3% | -$38,564 | ||||||
| M | 2023-02-13 | ANNX | Overdorf Michael | EVP, Chief Business Officer | S - Sale | $6.30 | -1,645 | 27,805 | -6% | -$10,368 | |||||
| M | 2023-02-13 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $6.31 | -1,908 | 29,542 | -6% | -$12,035 | |||||
2023-02-10 | ANNX | Satter Muneer A | Dir, 10% | P - Purchase | $6.80 | +2,647,058 | 7,056,024 | +60% | +$17,999,994 | ||||||
| D | 2022-07-07 | ANNX | Satter Muneer A | Dir | P - Purchase | $3.84 | +2,453,988 | 4,408,966 | +126% | +$9,423,314 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |